Results 251 to 260 of about 628,729 (310)

Allelic bias contributes to heterogeneous phenotypes of NK cell deficiency. [PDF]

open access: yesCell Rep
Seo S   +10 more
europepmc   +1 more source

Loss of SOCS1 in Donor T Cells Exacerbates Intestinal GVHD by Driving a Chemokine‐Dependent Pro‐Inflammatory Immune Microenvironment

open access: yesAdvanced Science, EarlyView.
T cell‐specific Socs1 knockout leads to inflammatory differentiation of CD8+ T cells, prompting the STAT1/2 complex to drive the activation of Ccl5, Ccr5, and Cxcr3, and promoting the skewing of monocytes toward a pro‐inflammatory M1 macrophage lineage.
Zhigui Wu   +14 more
wiley   +1 more source

CAR-T and CAR-NK cell therapies in AML: breaking barriers and charting the future. [PDF]

open access: yesJ Transl Med
Wu H   +8 more
europepmc   +1 more source

A framework integrating multiscale in silico modeling and experimental data predicts CAR-NK cell cytotoxicity across target cell types. [PDF]

open access: yesProc Natl Acad Sci U S A
Ahmad S   +11 more
europepmc   +1 more source

Distinct NK Cell Genetic Variants Are Associated With HSV-2 Versus VZV Infection of the CNS. [PDF]

open access: yesJ Med Virol
Graninger M   +4 more
europepmc   +1 more source

Precision sniper for solid tumors: CAR-NK cell therapy. [PDF]

open access: yesCancer Immunol Immunother
Li S   +8 more
europepmc   +1 more source

Subtype-specific NK cell-TAM interactions drive a novel prognostic signature in HNSCC. [PDF]

open access: yesFront Immunol
Zhao Z   +8 more
europepmc   +1 more source

Human NK cells and NK receptors

Immunology Letters, 2014
In early seventies "natural killer (NK) cells", a third lymphocyte subset was discovered that revealed an unexpected ability to kill syngeneic and allogeneic tumor targets, thus emerging as the most potent non-specific cytotoxic cells in both human and mouse. Decades of research revealed the multifaceted nature of these cells. Now we know that NK cells
BELLORA, FRANCESCA   +7 more
openaire   +3 more sources

NK CELL RECEPTORS

Annual Review of Immunology, 1998
▪ Abstract  NK cells are regulated by opposing signals from receptors that activate and inhibit effector function. While positive stimulation may be initiated by an array of co-stimulatory receptors, specificity is provided by inhibitory signals transduced by receptors for MHC class I.
openaire   +2 more sources

Home - About - Disclaimer - Privacy